Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Fagron NV: Disclosure of received notification

Fagron NV
Posted on: 06 Dec 17

Regulated information

Nazareth (Belgium)/Rotterdam (The Netherlands), 14 May 2018 

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the following notification.

Notification of JPMorgan Asset Management Holdings Inc., received on 10 May 2018

  • On 10 May 2018, Fagron received a notification that the shareholding of JPMorgan Asset Management Holdings Inc., a parent undertaking or a controlling person, has crossed the disclosure threshold of 5% on 8 May 2018 as the result of the acquisition of voting securities or voting rights.
  • On the notification date, JPMorgan Asset Management Holdings Inc., through JPMorgan Asset Management (UK) Limited, held a total of 3,602,460 voting rights.
  • Based on the denominator of 71,843,904 (total number of voting rights), in total JPMorgan Asset Management Holdings Inc., through JPMorgan Asset Management (UK) Limited, held on the notification date 5.01% of the total number of voting rights.
  • The full chain of controlled undertakings through which the holding is effectively held: JPMorgan Asset Management Holdings Inc. (100%), JPMorgan Asset Management International Limited (100%), JPMorgan Asset Management Holdings (UK) Limited (100%), JPMorgan Asset Management (UK) Limited (100%).
  • The notification of JPMorgan Asset Management Inc. can be viewed on via this link .

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

Please open the link below for the full press release:

Disclosure of received notification

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Fagron NV via GlobeNewswire

Last updated on: 15/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.